or
forgot password
  • cancer clinical trials in louisiana

  • Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Baton Rouge General Medical Center

    Trial Locations
    Baton Rouge General Medical Center
    Ochsner Clinic Foundation-Baton Rouge
    Hematology and Oncology Clinic
    Ochsner North Shore Medical Center
    Ochsner Clinic Foundation
    Tulane University Health Sciences Center
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Ochsner Clinic CCOP
    Ochsner Baptist Medical Center
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Hematology and Oncology Clinic

    Trial Locations
    Hematology and Oncology Clinic
    Louisiana State University Sciences Center- Monroe
    Louisiana State University
    Tulane University Health Sciences Center
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Highland Clinic
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Mary Bird Perkins Cancer Center

    Trial Locations
    Mary Bird Perkins Cancer Center
    Ochsner Clinic Foundation-Baton Rouge
    Hematology and Oncology Clinic
    Ochsner North Shore Medical Center
    Ochsner Clinic Foundation
    Tulane University Health Sciences Center
    Ochsner Clinic CCOP
    Ochsner Baptist Medical Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Ochsner Clinic Foundation

    Trial Locations
    Ochsner Clinic Foundation
    Ochsner Clinic CCOP
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Hematology Oncology Life Center

    Trial Locations
    Hematology Oncology Life Center
    Hematology Oncology Clinic, LLP
    Non-Small Cell Lung Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Children's Hospital New Orleans
    New Orleans, Louisiana 70118
    Hepatic Veno-Occlusive Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Tulane Cancer Center Office of Clinical Research

    Trial Locations
    Tulane Cancer Center Office of Clinical Research
    Mary Bird Perkins Cancer Center - Baton Rouge
    CCOP - Ochsner
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Tulane University Health Sciences Center
    Lung Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Louisiana State University Health Science Center

    Trial Locations
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
    Tulane University Health Sciences Center

    Trial Locations
    Tulane University Health Sciences Center
    Children's Hospital-Main Campus
    Childhood Atypical Teratoid/Rhabdoid Tumor
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Tulane University Health Sciences Center
    New Orleans, Louisiana 70112
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Prospective Observational Epidemiologic Study of Maraviroc's Safety
    Pfizer Investigational Site
    Shreveport, Louisiana 71103
    Human Immunodeficiency Virus
    A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Tulane University Health Sciences Center
    New Orleans, Louisiana 70112
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Mary Bird Perkins Cancer Center

    Trial Locations
    Mary Bird Perkins Cancer Center
    Baton Rouge General Medical Center
    Hematology and Oncology Clinic
    Tulane University Health Sciences Center
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
    LSU Health Sciences Center, Feist-Weiller Cancer Center
    Shreveport, Louisiana 71130
    Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Tulane Cancer Center Office of Clinical Research

    Trial Locations
    Tulane Cancer Center Office of Clinical Research
    Children's Hospital of New Orleans
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Ochsner Health Center - Bluebonnet
    Baton Rouge, Louisiana 70809
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific